This paper explores the meaning of higher risk status to women undergoing prenatal maternal screening for chromosomal anomalies.
INTRODUCTION
This paper will explore women's understandings of higher risk health status, drawing upon a study of prenatal screening for chromosomal anomalies. Higher risk status is constituted by screening systems operating at the limits of technological innovation where non-invasive and individually accurate tests are not yet available. At this frontier, non-invasive screening systems which divide populations into categories with lower and higher probabilities of experiencing a health problem may be developed. Those who screen above a defined risk threshold can then be offered accurate but invasive diagnostic tests. Higher risk status, although not the conditions tested for, is entirely constituted by the screening system. Screened individuals may realise that the results will change 'their' probability of encountering the selected problem, but cannot know the direction of this change.
Ethical issues concerning abortion and disability (Williams, Alderson and Farsides, 2002) would remain even if an affordable, non-invasive and accurate diagnostic test for chromosomal anomalies were available. Screening offers a second-best, probabilistic view of the unknown chromosomal status of the fetus, derived from empirical associations, usually neither causal or understood, between diverse markers and the screened condition. Since each marker differentiates populations with a greater prevalence of the condition, combining markers will improve prediction providing that the markers are not themselves closely associated. Probabilistic induction from populations to individuals requires heuristic acceptance of the ecological fallacy that aggregate properties of a category appertain to its members (Robinson, 1950; Greenland and Robbins, 1994; Heyman, Henriksen and Maughan, 1998) .
Heuristics offer simple rules concerning search, search termination and decisionmaking in complex environments (Gigerenzer and Selten, 2001, p. 8) . Heuristics mostly work well enough, but will not always provide a sound guide to action, the price paid for simplification. The probability heuristic will assign some individuals to the higher risk group who do not have the health problem in question and vice versa. The proportions of cases located in these two undesirable categories will depend upon the accuracy of the screening indicators used and the cut-off probability employed for differentiating lower from higher risk cases. With infrequent events, even a low percentage of higher risk cases leads to a large proportion of cases being located in this category despite not having the index condition (Gigerenzer 2003) . Table 1 illustrates this problem with respect to first trimester screening for Down's syndrome and other less common chromosomal anomalies (Bindra et al., 2002) . Table 1 shows that the positive predictive value, the proportion of true cases among those classified as being at higher risk as about 12% (75+54/1096) for this system. Although it is more accurate than second trimester screening (e.g. Canini et al., 2002) , about 90% of women who screen at higher risk will not be carrying a fetus with chromosomal anomalies. Because maternal age is included in the risk calculation, older women face a much lower positive predictive value than do younger women, but are less likely to screen at lower risk if carrying a fetus with chromosomal anomalies (Spencer, 2001) .
Suggestions for improving the predictive power of this screening system, for example by assessing structural heart defects (Fredouille et al., 2002) , are frequently put forward. However, increasing the number of markers may reduce the overall reliability of risk estimation as each marker may be affected by measurement error (Seth and Ellis, 1994) . Combining first and second trimester screening, as recommended by Wald, Watt and Hackshaw (1999) , would generate more accurate predictions but leave women waiting several weeks longer for their results. Prediction can also be improved by taking into account covariates of the screening markers, for example a previous higher risk classification in the absence of chromosomal anomalies, and a history of maternal smoking (Aitken et al., 2003) . Because of the atheoretical, weakly correlational nature of this form of knowledge, new candidate markers and covariates will be continually identified, subjecting established screening systems to constant pressure to change.
The social status of being at higher risk is constituted entirely by screening provision. Its costs are psychosocial and medical. A recent systematic review of the extensive available literature (Green et al., 2004) concluded that women, particularly younger women, experience an increase in anxiety after screening at higher risk which is not necessarily assuaged by a negative diagnosis. One possible explanation for the latter finding is that screening at higher risk for chromosomal anomalies makes the risk of other adverse outcomes more salient. Conflicting research conclusions have been drawn as to whether serious psychological reactions are common (Leithner et al., 2004) or uncommon (Goel et al., 1998) . The longer term impact of living temporarily with higher risk status is not known. Detection of higher risk through a scan rather than chemical markers may cause more anxiety (Weinans et al., 2004) , perhaps because it is associated with viewing the fetus. Green et al. (2004) hedge their conclusions with methodological cautions, for example that more anxious women may exclude themselves from studies by declining to complete questionnaires. Moreover, they reference average responses. Qualitative data, including our own, discussed below, documents the crucial mediating role of women's interpretations of being at higher risk.
Available accurate but invasive diagnostic tests, chorionic villus sampling (CVS) and amniocentesis, are associated with medical risks, including that of spontaneous abortion (Tabor et al., 1986) . The identified increase in risk is small, from 0.7% to 1.7% in the above large, randomised controlled trial of second trimester amniocentesis versus ultrasound screening, but is faced by all women who undergo diagnostic tests. Most will not be carrying a fetus with chromosomal anomalies. The chromosomal screening and testing system operates as an upwards risk escalator, since an initial risk assessment can lead to further interventions which in turn generate new psychosocial and medical risks (Heyman, 2005) .
The present paper will consider women's perspectives on becoming candidates for higher risk status, living with this status, and exiting from it when chromosomal anomalies are ruled out.
METHODOLOGY
Data were collected at two hospitals in suburban London selected to be comparable in terms of the socioeconomic and ethnic profiles of their surrounding populations. Both offer universal maternal prenatal screening for chromosomal anomalies. One hospital, the 'standard site', provides second trimester screening based on maternal age and serum testing. Those with an estimated probability of carrying a fetus with chromosomal anomalies greater than 1:250 are offered a diagnostic test, usually amniocentesis. Women have to wait one week for screening, and a further 10-21 days for diagnostic test results unless they pay for private testing. The survey indicated that that about twothirds of respondents underwent screening, and that about two-thirds of these women opted to pay for private nuchal translucency thickness screening via an ultrasound scan (Lewando Hundt et al., 2005) .
The 'innovative site' provides first trimester screening based on nuchal thickness, maternal age and serum testing. Women receive a pre-test consultation, screening and a post-test consultation about their combined risk estimate at a single one hour visit. Women whose probability of carrying a fetus with chromosomal anomalies is estimated to be greater than 1:300 are offered a diagnostic test, amniocentesis or CVS, with results delivered within one week. The innovative site generates more accurate screening results than the standard site. This gain is taken as a reduced proportion of chromosomal anomalies within the lower risk category for the same (5%) rate of women classified as at higher risk. The survey data indicated higher screening uptake at the innovative than at the standard site (Lewando Hundt et al., 2005) .
The research protocol was approved by the two local research ethics committees. Participants received an information sheet, and gave informed consent to be included in the study. The study design included surveys, interviews and transcription of consultations. The present paper draws primarily on lightly structured multiple interviews with 27 women, undertaken at different stages of their pregnancy, as summarised in Table 2 , below. The ethnicity, pregnancy and age profiles of the interview sample match those of the cachement areas for the hospital research sites (Lewando Hundt et al., 2005) . Three respondents were from non-White ethnic groups, and 17 were undergoing their first pregnancy. Five interviewees were aged over 35, putting them roughly into the current higher risk category on the basis of their age related probability (1:310) of chromosomal anomalies alone. Two of these older women screened at lower risk, two screened at higher risk and accepted diagnostic testing, and one opted for diagnostic testing without screening on account of her age (40). Four younger women, aged 34 or younger, screened at higher risk. Two of these women declined diagnostic testing.
After the pre-screening interviews had been completed, additional respondents were purposively sampled for post-screening/diagnostic testing interviews to cover different screening pathways. The full sample included: screening declined (5); screened at lower risk (14); screened at higher risk but declined diagnostic testing (2); received a diagnostic test (5); and miscarried before screening (1). These pathways were represented at each site. No chromosomal anomalies were diagnosed within the interview sample. Because of the low numbers in most of these groups, the findings should be regarded as illustrative rather than representative. Two transcripts of consultations about chromosomal risks will also be drawn upon, but analysis focuses mainly on women's retrospective views of the screening/diagnosis process. Overall, the sampling design allowed screening pathways to be explored prospectively and retrospectively at different pregnancy stages.
Hospital staff sent out introductory letters and information leaflets with the first appointment booking letter. Women were then approached personally at the clinic. Approximately half declined to participate at each site. Respondents were offered a choice of location, with most interviews taking place at their home. The interviews, which mostly lasted 60-90 minutes, covered a range of pregnancy related issues, but the present paper focuses on discussions of chromosomal screening and diagnostic testing. Consultations with a health care practitioner, usually a midwife, were tape-recorded, or transcribed using shorthand if consent to tape-record was not given. Only about 20% of women approached agreed to their consultation being taped. The interviews and consultations are not necessarily representative, but allowed a range of views to be explored. Inevitably, the reported study outcomes reflect the researchers' selection of data.
The qualitative interview data and consultation recordings were analysed thematically in relation to women's understandings of risk management for chromosomal anomalies. The categorisation was influenced by a previous study of risk management in prenatal chromosomal screening (Heyman and Henriksen, 2001) . The approach adopted fits well with framework analysis (Ritchie and Lewis, 2003) , i.e. systematic consideration of themes derived from the data. Data interpretations were discussed within the research team. However, the validity of the qualitative analysis offered needs to be judged by the reader.
DATA ANALYSIS
Data analysis explored the beginning, middle and end of women's encounters with higher risk status, in relation to the following four questions. How do risk considerations affect pregnant women's decisions to accept or reject screening? How do screened women manage the period of higher risk candidacy? What does being at higher risk mean to those who temporarily acquire this status? How do women understand their exit from higher risk status?
Information about each data extract, provided at the end of each quotation, includes a numerical case identifier indicating the site (1 innovative and 2 standard) with a unique identifier following the decimal point (e.g. 2.4), the participant's age, a brief indicator of the screening decision/outcome and the data source. With respect to screening outcomes, women were informed that they were at lower or higher risk of chromosomal anomalies depending on whether the overall probability of this outcome was below or above the threshold chosen by the screening site managers for recommending diagnostic testing (1:250 and 1:300 at the standard and innovative sites as outlined above).
Screening Decision-Making

Acceptance of Higher Risk Candidacy
Women who were screened and informed of their results faced a five percent probability that they would screen at higher risk. Hence, all screened women became candidates for higher risk status, which most would not acquire. Themes associated with acceptance of screening included routinisation of the procedure, use of a heuristic of trust to simplify complex probabilistic reasoning, engagement with the maternity care system through screening, and selective attention to screened for conditions. Exceptionally, women acquired higher risk status against their wishes.
Some women accepted screening without question, even though this decision placed them at risk of acquiring higher risk status. The survey showed that a much higher proportion of women attending the innovative site than of those attending the standard site agreed with the statement that screening was part of routine care, i.e. that its acceptance was unproblematic, and that it was assumed that they would be having it (Lewando Hundt et al., 2005) . The following discussion of a taped consultation illustrates how routine acceptance of screening for chromosomal anomalies could be accomplished.
Screening is introduced in the context of, as the midwife puts it, 'what we call a low risk pregnancy'. This context may lead women to conclude that their chromosomal screening status will also be low risk. Having outlined the screening procedure, the midwife describes its probabilistic logic.
Midwife: And then the computer churns out a piece of paper that says this woman's risk is one in a hundred, one in 1000, one in 10,000. It doesn't diagnose. That's the main thing to stress. It doesn't come out and say this woman has got a baby with an abnormality. It just puts into category of risk. This quotation illustrates the complexity of the probabilistic reasoning which health professionals attempt to communicate to service users. The cut-off of 1:300 used in this centre to differentiate lower from higher risk is justified in relation to the 'national average'. This interpretation naturalises the selected cutoff, obscuring its origin in a system-specific tradeoff between test sensitivity and specificity. The emphasis placed on computerised calculations, as against the assumptions behind them, gives the decision-making process an aura of objective description. The reference to a 5:100 'recall' rate appears to confuse the overall risk of receiving a higher risk test result (5%) with the risk of having a fetus with chromosomal anomalies given a higher risk screening result. The best estimate of the latter is a woman's screening result.
Qualitative analysis documents women's reasons for accepting screening. The unquestioning acceptance of screening is illustrated below. This woman employed trust in medicine as a heuristic substitute for engaging with the complex 'detail' of probabilistic inference. However, she may not have appreciated the cost of accepting screening, namely acceptance of the risk of acquiring higher risk status in the absence of chromosomal anomalies.
Another feature potentially linking the mere offer of screening to its acceptance is its association to engagement with the maternity care system. This woman had articulated the link between medical provision and risk selection. However, by defining the influence of medicine in terms of 'knowledge', she legitimated prioritising Down's syndrome over those of other conditions.
Acceptance of higher risk candidacy could be grounded in diverse projections about the future. For example, women who have ruled out diagnostic testing and termination may gamble that screening will generate a reassuring lower risk result (Heyman and Henriksen, 1998:183) . Women who accepted screening on the basis that they would proceed to diagnostic testing if they screened at higher risk were required to gauge their feelings about a hypothetical contingency, an issue explored in the next quotation.
We This woman had decided to only accept serum screening for conditions such as HIV which could be treated. The error in this case may have resulted from the same test media, blood and ultrasound, being used for different purposes. Unfortunately, she had screened at higher risk and was trapped in this status until her baby was born. She could not 'unknow' the information which put her into the higher risk category (Williams, Alderson and Farsides, 2002) .
Rejection of Higher Risk Candidacy
Women declined screening for various reasons, including rejection of its ultimate endpoint, abortion, challenging the risk selection implicit in the provision of screening for certain conditions, and avoidance of the anxiety arising from higher risk status. Ethical objections to abortion are illustrated below.
As I said earlier, we're Christians, and we've been praying to have a baby for years. Women who rejected pregnancy termination might still accept screening on the grounds of uncertainty reduction or in order to prepare themselves to care for a child with disabilities. However, this respondent, having ruled out abortion, saw no point in accepting screening.
Those who accepted screening took on an implicitly selective attitude towards risk concerns, as discussed above. Conversely, women who rejected screening could challenge its validity by declining to accept this attitude. Putting the available screening for chromosomal anomalies in a wider context reduced its perceived power to prevent the birth of a baby with health problems, thereby bolstering its rejection.
For some women, the risk of facing the worry associated with higher risk status influenced their decision to decline screening. As noted in relation to acceptance of higher risk candidacy, the rationale for her decision required this woman to make assumptions about how she would feel if she screened at higher risk.
Living with Higher Risk Candidacy
Screened women must live with uncertainty about their risk status until informed of their results. Contexts of risk interpretation associated with feeling anxious or not anxious are considered below.
Even the short wait required at the innovative site could generate considerable stress, as illustrated by the following consultation extract.
Midwife:
The combined risk is what we look at, and the cut-off point on the combined risk is 1 in 300, and your combined is 1 in 9,922 … 300 or less is a risk. This respondent took responsibility for the anxiety engendered by her higher risk candidacy, which she attributed to her neophyte status. The midwife's reference to 'stress' and her invitation to the woman to return to take classes reinforced service user ownership of anxiety about her risk status. The phrase '300 or less is a risk' nicely illustrates how an administratively determined cut-off for offering diagnostic testing could be transformed into an apparently natural property.
Women attending the standard site, who had to wait a week for screening results, did not necessarily experience high anxiety. The woman quoted below had been protected by optimistic assumptions which, unfortunately, were disconfirmed. 
Living with Higher Risk Status
Ascribing higher risk entails conversion of continuous probability values into a binary classification on the basis of an arbitrary cut-off. Differences in women's interpretations of and responses to this conversion are explored below. Women did not necessarily accept their higher risk classification, but some became highly distressed even if they appreciated its precautionary basis. Distress could be associated with self-blame, concealment of pregnancy and avoidance of identification with the fetus. Relationships with health professionals could become tense during this difficult waiting period.
The woman quoted below based rejection of the higher risk status ascribed to her on questioning the way in which probabilities were represented. Communication even of a relatively 'normal' probability of an adverse event made it seem possible, and therefore 'quite high'. One woman had correctly reasoned that the cut-off of 1:250 was based on the precautionary principle, i.e. maximising detection.
And if it's more than 1 in 250, you're called a high risk, which I think is a terrible phrase for it, because high risk really means more than a 50% chance, and it's not so. I actually came back with a 1 in 133, which is a one in point something percent chance, 0.75 I think we worked out the percent chance was, so hardly high risk. But, nevertheless, I don't suppose they take many chances. (2.15, aged 29, amniocentesis after higher risk screening, standard site, interview post-screening/diagnostic testing)
Despite identifying her risk status, which she labelled 'high' rather than 'higher', as precautionary, this woman experienced considerable distress during her three week waiting period (at the standard site) for her amniocentesis result.
You would have to, you know, to stop something like that you just wanted so desperately um. So, yeah, very difficult to deal with. And I tried to stop myself thinking about that until we had the results, and thought what's the point in upsetting myself and maybe upsetting the baby … And to a certain extent that worked as well … Just kept busy as much as I could, um, because you'd just sit at home and dwell on it. And it takes forever. (2.15, aged 29, amniocentesis after higher risk screening, standard site, postnatal interview)
During the waiting period for diagnosis, the status of the desperately wanted pregnancy became indeterminate. Although women may be told that most diagnostic tests generate negative results, higher risk status can take on a reality of its own. This woman's concern was heightened by fear that her anxiety might be transmitted psychosomatically to the baby. She used time management techniques in order to get through a three week waiting period during which subjective time had slowed down.
Some women looked to their own conduct for an explanation of their higher risk status, compounding anxiety with self-blame.
I had like, I think it was 'flu … I was taking painkillers for 10 days. I asked the midwife, 'Is it … something to do with them?'. You just feel, you look for answers, don't you? … And she said, 'No. It's just something that happens with genetics and chromosomes, nothing that you've done'. (1.1, aged 36, CVS after higher risk screening, innovative site, interview postscreening/diagnostic testing)
Her midwife had been able to reassure this respondent. As well as coping personally, women classified as at higher risk had to manage their relationships with others. The woman quoted below dealt with this issue through concealment, the requirements of which increased her distress. This respondent's estimated probability of having a baby with chromosomal anomalies had been given as 1:119 based on her age which reduced to 1:249 after serum screening. The hospital used a probability of 1:250 as the cut-off for recommending diagnostic tests, which, she commented, was 'just one below not high risk'. Ironically, she had been catapulted into higher risk status by a screening result which reduced her prior age-based probability of carrying a fetus with chromosomal anomalies. This woman's acceptance of a borderline higher risk attribution was influenced by her belief that the test is 'only 60/40 accurate'. However, the '60/40 problem', as this respondent described it, refers to the (40%) probability of woman screening at lower risk despite the presence of a fetal chromosomal anomaly. As she had screened at higher risk, this issue, of test sensitivity, did not apply to her case but, nevertheless, affected her understanding of being at higher risk.
Women placed in the higher risk category had to manage their relationships with health professionals whilst occupying this status. Two contrasting attitudes are illustrated below. The first respondent quoted valued the impartial but sympathetic thoroughness shown by the professional advising her. Service users will inevitably be treated differently, and will respond in diverse ways to the care they receive, particularly at a time of stress.
Exit from Higher Risk Status
Women lost their higher risk status when the chromosomal status of the fetus became known. The speed at which this transition was absorbed varied considerably. The respondent quoted below had moved easily from higher to no risk status.
I knew that it was definitely a normal result for Down's, and any other thing that they came back with would just be bad luck. There was no high risk of that. There was just as much chance of the other things as any other woman having a baby. So I relaxed. I was really pleased. (2.15, aged 29, amniocentesis after higher risk screening, standard site, postnatal interview)
One factor which might have contributed to the smoothness of this transition was her relief at a shortening of the waiting period for diagnosis. Initially informed that she would have to wait three weeks for diagnostics test results, this respondent then found that she could obtain partial results, including Down's syndrome for which she was at higher risk, within a week by purchasing private testing.
The transition from higher risk status sometimes required more than a diagnostic all clear, perhaps because the associated emotions could not be simply switched off, as the following quotation illustrates.
Although I do remember that the letter [confirming negative amniocentesis result] took a while to get here, and then I started to question myself a bit more … It was nice to get the letter, quite strangely, I don't know why, to have it in writing, that guarantee again. (2.1, aged 40, amniocentesis after higher risk screening, standard site, postnatal interview)
The health professionals who gave the above respondent this good news reminded her of its limitations. The difficulty experienced can be understood in terms of the tendency in riskoriented cultures to project uncertainty onto the external world. This projection may generate a belief that an individual placed into the higher risk category has a health problem. The above respondent found it difficult to understand that only the information about her baby, rather than the baby itself, had changed.
DISCUSSION
This paper has explored the process of chromosomal risk management at two maternity units operating 'standard' and 'innovative' screening systems. No claims are made about the typicality of the qualitative findings, which are designed more to illustrate 'what things "exist" than to determine how many such things there are' (Walker, 1985, p. 4) .
As the UK and other countries move towards offering prenatal chromosomal screening universally, an increasing number of women will have to manage the psychosocial sequelae of higher risk status. Moreover, the advent of universal prenatal chromosomal screening reflects a wider shift towards a mode of health care in which concern for the individual case is replaced by a focus on the sorting of populations by risk indicators (Castel, 1991) . Screening subjects its users to the risk of acquiring higher risk status. Its medical and psychosocial downsides have to be balanced against both the societal and personal gains arising from earlier detection of health problems and reassurance, for the majority, arising from the acquisition of lower risk status.
The data presented above document the complex processes through which the provision of screening technology influences risk perceptions. Midwives and doctors (Heyman and Henriksen, 2001) can struggle to explain the complexities of probabilistic induction. Some women accept healthcare on the basis of trust, a process likely to be accentuated as an innovative form of healthcare becomes routinised (Press and Browner, 1997) . Although the qualitative findings, involving small numbers of women on different screening pathways, did not generate evidence of differences between the standard and innovative sites, the survey findings cited above show that women who were processed through the latter more technically advanced and automated system were more likely to view prenatal chromosomal screening as routine and to accept screening. Acceptors may not appreciate that by accepting screening they become candidates for higher risk status. Qualitative data document the interpersonal processes underlying routinisation.
Responsibility for the 'quality control' of the fetus falls mainly on women (Rapp, 1999: 87) . Decision-making about screening requires women to predict how they would feel in hypothetical future situations (Williams et al., in press ). Santalahti et al. (1998) found that only half of the women who said that they would decline a termination after a positive amniocentesis result actually did so. This analysis raises troubling issues concerning the possibility of informed consent as advancing technology widens the scope for screening provision. Although its critics may struggle to suggest preferable alternatives, the limitations of the principle of informed consent, particularly its discounting of the social processes determining the menu of choices available and influencing individual decisions (Corrigan, 2003) , need to be acknowledged. Health professionals need to clearly understand probabilistic reasoning and to appreciate the difficulty of communicating risk information effectively. As screening technology becomes more powerful, increasing amounts of information can be obtained from the same source, e.g. blood tests. Care needs to be taken to avoid patients being inadvertently being given information about their risk status, for example in patient-held records, which they have opted not to receive.
Screening creates a new, usually transient, role of living with higher risk status. The present study illustrates two challenges to the validity of this attribution. Firstly, the limited scope of chromosomal screening in relation to the overall range of pregnancy-related health problems could be noted. This challenge undermines the tacit selection of risks as targets for concern which is embedded in the provision of particular risk management systems. Secondly, the transformation of quantitative probabilities into the qualitative categories of 'higher' versus 'lower' risk could be questioned.
Those study participants who accepted higher risk status experienced varying degrees of distress during the waiting period for diagnostic test results, a time of arguably tentative pregnancy (Rothman, 1994) . They treated their screening result as 'positive', i.e. indicative of a likely problem, even when they clearly understood that this categorisation arose from being above a precautionary threshold. Such reactions should not be dismissed as mere misunderstanding, a view expressed by 80% of a sample of obstetricians (Green, 1994) . More attention needs to be given to the needs of women who screen at higher risk (Green et al., 2004) , and primary care professionals need to be more engaged in supporting them (Statham, Solomou and Green, 2003) . Women will occasionally acquire higher risk status unintentionally through receiving results from screening tests which they had declined. Such accidents may become more likely as the same medium, e.g. blood tests or scans, are used for more and more screening purposes as technology advances. Women who acquire higher risk status inadvertently may be in particular need of support, and their inadvertent acquisition of higher risk status should be noted on their records. Exiting from higher risk status was not always straightforward. Similarly, Weinans et al. (2000) found that 13% of the women they surveyed continued to feel anxious after amniocentesis had ruled out chromosomal anomalies.
The operation of screening systems marks some service users as at higher risk, and therefore in need of further investigation. These service users, who cannot be identified in advance, pay the price of living with higher risk status so that all can be given the option of taking preventative action if the conditions being screened for are eventually identified.
